Aras Mattis, M.D., PH.D

NPI: 1326374869
Total Payments
$24,704
2024 Payments
$6,496
Companies
4
Transactions
16
Medicare Patients
179
Medicare Billing
$15,658

Payment Breakdown by Category

Other$12,596 (51.0%)
Consulting$8,401 (34.0%)
Education$3,706 (15.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,596 7 51.0%
Consulting Fee $8,401 8 34.0%
Education $3,706 1 15.0%

Top Paying Companies

Company Total Records Latest Year
BioMarin Pharmaceutical Inc. $21,922 9 $0 (2024)
Regeneron Pharmaceuticals, Inc. $1,967 5 $0 (2024)
Becton, Dickinson and Company $500.00 1 $0 (2023)
Illumina, Inc. $315.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,496 4 BioMarin Pharmaceutical Inc. ($5,934)
2023 $2,220 5 Regeneron Pharmaceuticals, Inc. ($1,405)
2022 $15,987 7 BioMarin Pharmaceutical Inc. ($15,987)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
08/23/2024 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $281.00 General
08/23/2024 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $281.00 General
10/17/2023 Illumina, Inc. Oncology Testing (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $315.00 General
Category: Genetics
10/03/2023 Becton, Dickinson and Company Consulting Fee Cash or cash equivalent $500.00 General
04/06/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $281.00 General
02/24/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $562.00 General
02/24/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $562.00 General
12/16/2022 BioMarin Pharmaceutical Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $375.00 General
11/18/2022 BioMarin Pharmaceutical Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,406.25 General
10/21/2022 BioMarin Pharmaceutical Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,393.75 General
09/23/2022 BioMarin Pharmaceutical Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,418.75 General
08/19/2022 BioMarin Pharmaceutical Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,312.50 General
06/24/2022 BioMarin Pharmaceutical Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $375.00 General
04/11/2022 BioMarin Pharmaceutical Inc. Education In-kind items and services $3,706.19 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 3 34 72 $20,136 $3,634
2020 6 145 273 $71,387 $12,024
Total Patients
179
Total Services
345
Medicare Billing
$15,658
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88309 Pathology examination of tissue using a microscope, high complexity Facility 2021 11 15 $12,195 $2,029 16.6%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2021 11 39 $4,719 $1,023 21.7%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2021 12 18 $3,222 $581.44 18.0%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2020 26 45 $21,870 $3,691 16.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 38 76 $17,984 $2,529 14.1%
88341 Special stained specimen slides to examine tissue Facility 2020 19 78 $9,346 $2,224 23.8%
88309 Pathology examination of tissue using a microscope, high complexity Facility 2020 14 15 $12,055 $2,196 18.2%
88342 Tissue or cell analysis by immunologic technique Facility 2020 28 32 $5,659 $1,096 19.4%
88304 Pathology examination of tissue using a microscope, moderately low complexity Facility 2020 20 27 $4,473 $289.17 6.5%

About Aras Mattis, M.D., PH.D

Aras Mattis, M.D., PH.D is a Anatomic Pathology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1326374869.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aras Mattis, M.D., PH.D has received a total of $24,704 in payments from pharmaceutical and medical device companies, with $6,496 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,596).

As a Medicare-enrolled provider, Mattis has provided services to 179 Medicare beneficiaries, totaling 345 services with total Medicare billing of $15,658. Data is available for 2 years (2020–2021), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Anatomic Pathology
  • Location San Francisco, CA
  • Active Since 10/18/2009
  • Last Updated 10/18/2009
  • Taxonomy Code 207ZP0101X
  • Entity Type Individual
  • NPI Number 1326374869

Products in Payments

  • Oncology Testing (Device) $315.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology Doctors in San Francisco